Some of the infrastructure bioscience startups have taken for granted can no longer be relied upon without a backup plan (or two) in place. Interrupted supply chains, revenue-starved hospital systems, nationwide lockdowns — entrepreneurs must consider new vulnerabilities to their businesses and make plans to mitigate them. This session explores anticipated new challenges and discusses ways to lessen risk, whether you’re a new executive or an experienced inventor. The second in our four-part Business of Bioscience series, these BioEDU webinars take place every Thursday at 9:00 a.m. through June 4 and feature live conversations with bioscience industry veterans. Particular emphasis will be given to concerns relevant to healthcare startups in a post-COVID environment.
- Director of Talent and Expansion Tyler Allchin, moderator
- VP of Strategic Partnerships Matt McBride
- Executive-in-Residence BioEnterprise, Bounce Innovation Hub, William Flickinger
- Executive-in-Residence BioEnterprise, Pete O’Neill